FDA Turns Off Otsuka’s Abilify Dimmer Switch Graphic
This article was originally published in The Pink Sheet Daily
Executive Summary
As lights go out on the franchise, FDA says pharmacology aid misleadingly suggests Abilify offers advantages over other treatments.